AGTR1 and heart failure: In a heart failure model in mice, miR-342-3p was among four miRNAs that were significantly downregulated in plasma and was used successfully as a biomarker to assess the efficacy of azilsartan medoxomil, an angiotensin II type 1 receptor blocker [44].